Subcutaneous (SC) single dose: Clinical Trials

2 trials of Subcutaneous (SC) single dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 2

Follow Subcutaneous (SC) single dose: new trials by email Literature Review of Subcutaneous (SC) single dose trials Research Report on Subcutaneous (SC) single dose

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects
Subcutaneous (SC) single dose - Hypertension (HTN)
Phase 1CompletedArnatar Therapeutics, Inc.402024-01-182026-04-14
A Single Dose Pharmacokinetics (PK) Study of GSK2434735 in Healthy Male Volunteers
Intravenous (IV) single dose, Subcutaneous (SC) single dose - Asthma
Phase 1CompletedGlaxoSmithKline52012-02-132017-06-20

Conditions studied

Asthma (1)  ·  Hypertension (1)

Sponsors

Arnatar Therapeutics, Inc. (1)  ·  GlaxoSmithKline (1)

Countries

China (1)  ·  United Kingdom (1)

Top investigators

Ruihua Dong (1)